| Identification | Back Directory | [Name]
VILAZODONE | [CAS]
163521-12-8 | [Synonyms]
VILAZODONE
EMD 515259
Vilazodonei
Vilazodone-d6
Vilazodone HCL
Vilazodone [inn]
5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide
5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide
2-BenzofurancarboxaMide,5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-
5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide
Vilazodone
5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide
5-(4-(4-(5-cyano-1H-indol-3-yl) butyl) piperazin-1-yl) benzofuran-2-carboxaMide hydrochloride | [EINECS(EC#)]
1308068-626-2 | [Molecular Formula]
C26H27N5O2.ClH | [MDL Number]
MFCD09838919 | [MOL File]
163521-12-8.mol | [Molecular Weight]
477.993 |
| Chemical Properties | Back Directory | [Melting point ]
203-205°C | [Boiling point ]
745.1±60.0 °C(Predicted) | [density ]
1.34±0.1 g/cm3(Predicted) | [storage temp. ]
Refrigerator | [solubility ]
DMSO (Slightly)), Methanol (Slightly) | [form ]
Solid | [pka]
15.98±0.30(Predicted) | [color ]
Pale Yellow to Beige | [Stability:]
Very Hygroscopic | [CAS DataBase Reference]
163521-12-8 |
| Hazard Information | Back Directory | [Chemical Properties]
Light Yellow Solid | [Usage]
An inhibitor of ST and activator of SR-1A | [Usage]
It is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression. | [Usage]
Labelled analogue of Vilazodone | [Uses]
An inhibitor of ST and activator of SR-1A | [Uses]
It is a combined serotonin specific reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist currently under clinical evaluation for the treatment of major depression. | [Uses]
Labelled analogue of Vilazodone | [Definition]
ChEBI: A 1-benzofuran that is 5-(piperazin-1-yl}-1-benzofuran-2-carboxamide having a (5-cyanoindol-3-yl)butyl group attached at position N-4 on the piperazine ring. Used for the treatment of major depressive disorder. | [Originator]
Merck KGaA (Germany) | [Brand name]
Viibryd | [storage]
Store at -20°C |
| Questions And Answer | Back Directory | [Description]
Vilazodone is a kind of serotonergic antidepressant developed by Merck KGaA Company. It is a novel compound with high affinity and selectivity for the 5-hydroxytrptamine (5-HT) transporter and 5-HT (1A) receptors. It is indicated for the treatment of major depressive disorder (MDD). It is can be used as an alternative drugs for other kind of antidepressant classes drugs that can’t be tolerated by patients. As a selective serotonin reuptake inhibitor, vilazodone can prevent the serotonin from re-entering into cell bodies, therefore making it remain longer inside the synapse. Moreover, it has a high selectivity for the serotonin-1A receptor, taking effect as a partial agonist that can simulate the production of serotonin. These effects result in increased serotonin in the synaptic cleft. This effect is related to the antidepressant effect of vilazodone in vivo.
| [References]
https://www.drugbank.ca/drugs/DB06684
https://en.wikipedia.org/wiki/Vilazodone
http://www.rxlist.com/viibryd-drug/indications-dosage.htm
|
|
|